Advertisement Dara BioSciences names new board member - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Dara BioSciences names new board member

US-based pharmaceutical company Dara BioSciences has appointed Gail Lieberman to its board of directors. The appointment fills a vacancy that had previously existed on the company's board.

Ms Lieberman is the founder and managing partner of Rudder Capital, which provides financial and strategic advisory services for middle-market companies including M&A advisory and strategic consulting.

Ms Lieberman has recently served as a director for three public companies in the healthcare and aerospace sectors: I-Trax, chair of audit committee, member of compensation and strategy committees, 2004-2008; TriPath Imaging, member of audit and governance committees, 2005-2006; Breeze-Eastern Corporation, chair of audit committee, member of strategy committee, 2005-2007.

Ms Lieberman said: “I am pleased to be associated with a company that has significant growth prospects and offers so much hope through the products it develops.”